Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin.
about
The design and characterization of two proteins with 88% sequence identity but different structure and functionGram-positive anaerobic cocci--commensals and opportunistic pathogensHeme-based catalytic properties of human serum albuminCrystal structure of a bacterial albumin-binding domain at 1.4 A resolutionStructural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA moduleA minimal sequence code for switching protein structure and functionA fluorescent fatty acid probe, DAUDA, selectively displaces two myristates bound in human serum albuminMutational Tipping Points for Switching Protein Folds and FunctionsStructures of bovine, equine and leporine serum albuminFusion to a highly stable consensus albumin binding domain allows for tunable pharmacokineticsEngineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albuminCirculatory zinc transport is controlled by distinct interdomain sites on mammalian albumins.Engineering of a femtomolar affinity binding protein to human serum albumin.Engineering bispecificity into a single albumin-binding domain.Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cellsRatiometric analysis of fluorescence lifetime for probing binding sites in albumin with near-infrared fluorescent molecular probes.Novel high-affinity binders of human interferon gamma derived from albumin-binding domain of protein G.Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain.In silico prediction of human serum albumin binding for drug leads.Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3.Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of actionThe albumin-binding domain as a scaffold for protein engineering.Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen.Evaluation of an Albumin-Binding Domain Protein Fused to Recombinant Human IL-2 and Its Effects on the Bioactivity and Serum Half-Life of the Cytokine.Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.Interactive association of drugs binding to human serum albumin.Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.An artificially evolved albumin binding module facilitates chemical shift epitope mapping of GA domain interactions with phylogenetically diverse albumins.Molecular dynamics simulations on the conformational transitions from the GA 98 (GA 88) to GB 98 (GB 88) proteins.An Escherichia coli trap in human serum albumin microtubes.GA/GB Fold switching may modulate fatty acid transfer from human serum albumin to bacteria
P2860
Q24680766-7ADD22E1-7261-4C9A-928F-183975ED36CFQ26827994-E1F9EDD4-F4FE-43CE-B357-5C38AA281C48Q26828438-AE496E76-38A4-4754-9289-F82A114F4AB4Q27646035-7085CADC-D5D5-46C1-997C-D5A6980DFACBQ27649811-3DA95B54-3A40-4F6E-ACCA-015F77E57872Q27658235-E8DD067A-26F3-4C2B-BB39-1DDF3CCDEAFDQ27675025-A897BE6F-209A-4B9D-BBEE-330EE866C6DCQ27677203-61BC0C96-DFF1-4322-BB51-2307B70479FFQ27682313-F97D0E1E-C707-4C55-BB45-3BE7B6AED475Q27701821-0BBBE1CE-AD90-4442-8092-E9C0057AED78Q28541561-CC7D7963-8BF3-4A1C-A17D-DA486EBB3AF6Q30252235-D5CEAEEA-38D6-4EEE-8210-111216E59204Q30844011-AE99EA06-BBA4-444B-AA34-2C3C6800A52BQ31032588-F55BE696-72B5-4EE9-B6B3-A18AF9C1D3ECQ31151707-EB0046ED-8AAF-4F62-ABDA-503E54F620E3Q33306584-1B83BBEF-B4A6-41EC-BCDA-45DF20A453B9Q34082509-8A024BBA-38BD-4C11-B54E-E1BC8F781542Q34568391-A7787012-17E5-4062-8C19-0BE476212D8FQ34609144-00683B31-5814-4A74-8A11-D9C89159DBD2Q34752052-2A48E840-06DA-415C-9FFC-D274E3560680Q35087618-C1EB9509-3D6F-4351-8C36-B7487734D31CQ35136577-07E94CD1-7B27-4F73-A76F-F3C69488EB47Q37115986-5DA8A7C1-7C8E-41AD-B6CA-9EE84F4D84C1Q37611373-D707C27E-3E48-4498-ABDE-A0920B2BF61BQ38083035-4D6AE225-74CC-4342-AC5F-EE1CEBC82E3AQ38192435-F3123FEA-EFA1-41A4-B958-7FD30F46D963Q39029672-215752D9-A9C6-4EAC-A79E-2644E063E73FQ42964110-24B047FD-96D8-4DFE-8675-199C4675C6D8Q51601311-1167967B-3B0C-4D0B-B93A-58672E317541Q53521666-2367C719-7F58-4E67-AF80-A678067D82A2Q58616886-DCF83537-360F-4A49-A270-11DD88508893
P2860
Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Crystal structure and biologic ...... plex with human serum albumin.
@ast
Crystal structure and biologic ...... plex with human serum albumin.
@en
type
label
Crystal structure and biologic ...... plex with human serum albumin.
@ast
Crystal structure and biologic ...... plex with human serum albumin.
@en
prefLabel
Crystal structure and biologic ...... plex with human serum albumin.
@ast
Crystal structure and biologic ...... plex with human serum albumin.
@en
P2093
P2860
P356
P1476
Crystal structure and biologic ...... plex with human serum albumin.
@en
P2093
Inga-Maria Frick
Lars Björck
Mats Wikström
Sara Lejon
Stefan Svensson
P2860
P304
42924-42928
P356
10.1074/JBC.M406957200
P407
P577
2004-07-21T00:00:00Z